๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Anticipatory nausea and vomiting in the era of 5-HT3antiemetics

โœ Scribed by G. R. Morrow; Joseph A. Roscoe; Jeffrey J. Kirshner; Harry E. Hynes; Richard J. Rosenbluth


Publisher
Springer-Verlag
Year
1998
Tongue
English
Weight
30 KB
Volume
6
Category
Article
ISSN
0941-4355

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Anticipatory nausea and vomiting: broade
โœ Maggie Watson ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 691 KB

Anticipatory nausea and vomiting, as a side-effect of cancer chemotherapy, is a well-recognised phenomenon known to affect a substantial minority of patients. Although explicable using a conditioning model, it may have a complex aetiology with affective and cognitive elements as well as specific pha

GR38032F, a 5HT3receptor antagonist, in
โœ Michel Marty; Jean P. Droz; Pierre Pouillart; Bernard Paule; Nils Brion; Jacques ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› Springer ๐ŸŒ English โš– 330 KB

A total of 28 patients receiving cancer chemotherapy with cisplatin-containing regimens (70-120 mg/ m 2) participated in an evaluation of the efficacy and safety of GR38032F for the prevention of acute nausea and vomiting. GR38032F, a 5HT3 receptor antagonist, was given 30 min prior to cisplatin as